Winette Van Der Graaf: How can RWD and trials support evidence together?

Winette Van Der Graaf shared a post on X:

“So we started with Cancer Drug Development Forum – EORTC workshop on Rare Cancers in Amsterdam with Francesco Pignatti EU Medicines Agency.

Patients unmet needs are obvious!

How can RWD and trials support evidence together?

We need to think in an innovative way.”

Source: Winette Van Der Graaf/X

Winette van der Graaf is the President of the European Organization for Research and Treatment of Cancer (EORTC). She is a professor and the head of medical oncology Department at the Netherlands Cancer Institute (Amsterdam), Professor of Oncology at Erasmus MC (Rotterdam).

Prior to that, she was a professor at Institute of Cancer Research and Honorary Consultant at Royal Marsden Hospital (London, UK), Professor and Head of Medical Oncology Department at the Radboud University Nijmegen Medical Centre.